Who makes Septolete Total?

Septolete Total is developed by Valenta Pharm JSC.

Last reviewed 2026-04-19 · How we verify

Septolete Total

Valenta Pharm JSC · Phase 2 active Small molecule

At a glance

Generic name	Septolete Total
Also known as	benzydamine + cetylpyridine chloride
Sponsor	Valenta Pharm JSC
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Study to Evaluate the Efficacy and Safety of Different Doses of Graminidin With Anesthetic, a Metered Dose Topical Spray, in the Treatment of Acute Infectious and Inflammatory Pharyngeal Diseases Compared With Drug Septolete Total, Lozenges (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Septolete Total CI brief — competitive landscape report
Septolete Total updates RSS · CI watch RSS
Valenta Pharm JSC portfolio CI